Smofkabiven Peripheral 0.4 mg

SMOFKABIVEN Peripheral 0.4 mg is an intravenous emulsion containing zinc sulfate heptahydrate, designed for nutritional support. This product is manufactured by Fresenius Kabi Canada Ltd and is available in various pack sizes.

SMOFKABIVEN Peripheral 0.4 mg is primarily used for nutritional support in patients who require intravenous nutrition. It contains zinc, an essential mineral that plays a crucial role in various bodily functions, including immune function, wound healing, and metabolism. This emulsion is often used in clinical settings where oral nutrition is not feasible or sufficient.

The effects of SMOFKABIVEN Peripheral 0.4 mg are primarily related to its nutritional content. Zinc sulfate heptahydrate helps to maintain adequate zinc levels in the body, which can support overall health and well-being. Patients may experience improved nutritional status and better recovery outcomes when used as directed by a healthcare professional.

SMOFKABIVEN Peripheral 0.4 mg should be handled with care and administered under the supervision of a healthcare professional. It is important to follow proper storage and handling guidelines to ensure the integrity of the emulsion. Patients with known allergies to any of the components should avoid using this product. Always consult a healthcare provider before starting any new nutritional regimen.

SMOFKABIVEN Peripheral 0.4 mg may interact with certain medications or supplements. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Additionally, patients should be cautious when consuming alcohol or other substances that may affect nutritional absorption or metabolism.